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Non-iron mediated alteration in hepatic transferrin gene expression in
the nephrotic rat. Both transferrin and the iron it carries are lost in the
urine in the nephrotie syndrome. Patients may develop hypochromie
microcytic anemia and synthesis of transferrin, a protein regulated in large
part by iron availability, is increased. Transferrin synthesis has also been
reported to be increased in liver slices from rats with hereditary analbu-
minemia, and their plasma transferrin levels are increased, suggesting that
transferrin synthesis may be stimulated by processes other than iron
depletion in this hypoalbuminemic condition. Transferrin metabolism was
studied in rats with Heymann nephritis (RN), in a strain of Sprague-
Dawley (SD) rats with hereditary analbuminemia [Nagase analbuminemic
rats (NAR)], and in normal SD rats. Plasma transferrin concentration and
mass was decreased significantly in RN, but increased in NAR. Trans-
ferrin synthesis was increased both in NAR (measured either as the
disappearance of [1251] labeled transferrin or as the incorporation of [3H]
phenylalanine) and in RN (incorporation of ['R] phenylalanine). The
fractional rate of transferrin catabolism was unchanged in NAR. Thus
transferrin mass was increased in NAR entirely as a consequence of
increased synthesis. Transferrin and albumin synthesis correlated with one
another in both RN and SD (P < 0.001). Transferrin mRNA was
increased in both RN and NAR and was unaffected by administration of
iron to RN. Repatic transferrin and albumin mRNA levels were also
correlated positively in RN and SD, suggesting that increased hepatic
synthesis of both proteins might be responding to the same stimuli.
Transferrin gene transcription was increased in both RN and NAR and
was unaffected by administration of iron to HN. Transferrin mRNA was
not increased in the testis in either RN or NAR, suggesting that
augmentation in transferrin gene expression is driven by a non-iron
dependent process and is confined to the liver.
Transferrin synthesis is increased in patients with the nephrotic
syndrome [1]. Transferrin is the principal iron carrying protein in
plasma [2]. Its urinary loss in the nephrotic syndrome is sufficient
to reduce plasma transferrin levels [31 and may produce sufficient
iron losses to cause microcytic anemia [4—6]. Thus increased
synthesis of transferrin in the nephrotic syndrome could well be a
normal physiologic response to this well recognized regulatory
stimulus. Although transferrin is synthesized in extrahepatic tis-
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sues, iron deficiency specifically causes increased transcription of
the transferrin gene in the liver, but not in extrahepatic sites [7].
Analbuminemic rats and humans lack the ability to synthesize
albumin in all but very small amounts [8, 9]. Although plasma
albumin concentration is nearly zero in these animals, the con-
centration of several other non-albumin plasma proteins of similar
size, including transferrin, is increased [10]. Transferrin is present
in higher concentrations than are other proteins of similar molec-
ular weight, and contributes significantly to the normal plasma
protein concentration in these animals. Transferrin synthesis has
been reported to be increased in liver slices from these animals
[11], suggesting that increased synthesis contributes to the in-
creased plasma concentration of this protein in analbuminemia. It
is not known whether changes in the rate of transferrin catabolism
also contribute to the increased plasma levels of this protein in
these animals.
Urinary protein loss is accompanied by increased hepatic
synthesis of several secreted proteins, albumin [1], apolipopro-
teins [12], and coagulation factors [13, 14], regardless of whether
they are lost in the urine. Although albumin is synthesized nearly
exclusively in the liver, several of these proteins are synthesized in
extrahepatic tissues as well as well as in the liver. Apo A-I mRNA
levels are increased in liver [15, 16], but not in the intestine [15] in
nephrotic rats, suggesting that synthesis of this protein is in-
creased primarily in the liver. While transferrin is primarily
synthesized in the liver [17], small amounts of transferrin are also
synthesized in testis and brain [7, 18]. Repatic transferrin gene
transcription, but not that in other tissues, is regulated by the
availability of iron [7, 17].
Protein synthesis may be regulated at several steps, or may
change in one organ, but not in another. Although the hepatic
synthesis of some proteins may be increased in the liver at the
level of transcription [13, 15, 16], expression of the same gene may
not change in other tissues that express it, such as gut in the case
of apo A-I in the nephrotic syndrome in the rat [15]. Furthermore,
even though synthesis of a group of proteins may be increased in
the liver, such as apolipoproteins A-I, B and E in the nephrotic
syndrome [12], the mechanism responsible for increased synthesis
may be different. While apo A-I is increased transcriptionally, apo
B and E transcription rates are unchanged [16]. Although albumin
synthesis is increased at the transcriptional level in the nephrotic
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Table 1. Transferrin and albumin synthesis in nephrotic, analbuminemic and normal rats
Weight
Liver
Weight
Transferrin Albumin
synthesis synthesis Albumin/
transferrin
Serum
iron
pgidl
Serum
Transferrin
mg/mi
Urinary
transferrin
mg/day
Serum
albumin mgi
ml
Urinary
albumin
mg/dayGroup g 3H incoi'p
SD 300 4.3 12.9 0.63" 294 45b 6600 750" 25.8 3.7" 201 24 4.81 0.17" NM 19.64 1.08 NM
N = 13
HN 310 9.8 16.5 0.7P" 1102 335ab 17000 3600a 25.34 96b 130 13°" 0.69 001°" 127 15 2.89 1.21° 517 90
N= 7
NAR 291 6.9 13.2 0.72 521 86° 31.9 32° 0.092 0.091° 198 59 7.06 0.19° NM NM NM
N = 13
Measurement of transferrin synthesis (incorporation of [3H] phenylalanine into hepatic transferrin in 15 mm) in normal (SD), rats with Heymann
nephritis (HN) and Nagase analbuminemic rats (NAR). Transferrin and albumin synthesis are in immunoprecipitable counts incorporated/gram
rat/hour. Urinary albumin and transferrin were only measured in HN. Data are means 5EM. NM connotes not measured.
a P < 0.05 vs. SD
"P C 0.05 vs. NAR
syndrome [19, 201, albumin synthesis is increased at the post-
transcription level following refeeding [21—23].
It is not known whether transferrin mRNA levels are altered in
extrahepatic tissues in either the nephrotic syndrome or heredi-
tary analbuminemia, or whether instead, like apo A-I, any changes
in expression of this gene are also primarily confined to the liver.
Indeed, it is not known if increased transferrin synthesis occurs in
the liver in the nephrotic syndrome, and if hepatic transferrin
synthesis is increased it is unknown if it is regulated, at least in
part, transcriptionally.
We wanted to determine whether transferrin synthesis was
increased transcriptionally in the nephrotic syndrome, whether
iron depletion was possibly the proximate stimulus, and whether
transferrin synthesis was increased at the transcriptional level in
analbuminemic rats. We also wanted to determine whether in-
creased plasma transferrin levels in analbuminemic rats was a
consequence of increased synthesis, decreased catabolism or a
combination of both processes. Since these animals have no
urinary protein losses, and presumably normal iron levels, finding
a similar regulatory mechanism in analbuminemic and nephrotic
rats would suggest that iron losses are not responsible for in-
creased production of transferrin in these two conditions of
reduced plasma albumin concentration, but instead that trans-
ferrin synthesis may be regulated as part of the response to
changed plasma protein composition in both conditions.
Methods
Protocol 1. Transferrin synthesis in the rat with Heymann nephritis
and in the analbuminemic rat
Nagase analbuminemic rats (NAR) were raised in our own
colony, originally derived from a colony of animals donated to us
by Dr. Nagase. Every four generations NAR males were bred with
normal Sprague-Dawley (SD) female rats and the subsequent fi
generation was back bred with NAR males. The resulting f2
generation was subsequently tested for the presence of serum
albumin using immunochemical techniques.
Synthesis of both transferrin and albumin were directly mea-
sured in the liver of NAR (N = 13), HN (N = 7) and SD rats (N
= 13) using the incorporation of [3H] phenylalanine into these
proteins [24] (Table 1). In this method a high dose (50 MCi/100 g
body weight) of L-[4-3H]phenylalanine was combined with a
flooding dose of unlabeled phenylalanine and injected into awake
animals through a tail vein. Animals were anesthetized using an
intraperitoneal injection of sodium pentobarbital (60 mg/kg for
non-nephrotic rats, 20 mg/kg for HN). The abdomen was incised
and the animals exsanguinated by aortic puncture 30 minutes after
injection of phenylalanine.
Albumin and transferrin were each precipitated using specific
antibodies. Two grams of liver were homogenized in 10 ml of lysis
buffer (150 m of phosphate buffer saline with 0.5% deoxycholic
acid and 0.5% NP-40) using a polytron homogenizer (Kinemati-
cer, Luzerne, Switzerland). The cellular debris were removed by
centrifugation at 3000 rpm for 15 minutes (Damon CRU 5000,
International Equipment Company, Needham Heights, MA,
USA). One ml aliquot of supernatant was incubated with 0.1 ml of
washed protein A bearing Staphylococcus aureus cells (Pansorbin,
CalBiochem-Behring Diagnostics, San Diego, CA, USA) for 15
minutes at 4°C and then centrifuged at 12000 rpm for one minute
(Beckman-inicrofuge 12, Beckman Instruments Inc., Palo Alto,
CA, USA). An aliquot of the supernatant was then incubated over
night at 4°C with rabbit anti-rat transferrin antibody (Cappel,
Organon Teknika, Durham, NC, USA). The amount of antibody
used was determined by titration against a constant amount of
antigen. The immune complexes formed were purified by incu-
bating 1.0 ml samples for 30 minutes at 4°C with 0.1 ml of washed
Pansorbin and followed by centrifugation at 12000 rpm for 30
minutes. The pellet was washed with one ml of lysate buffer three
times, and then dissolved in NaOH and counted in liquid scintil-
lation counter (Searle Analytic Co., Des Plaines, IL, USA). The
pellet was resuspended and repeatedly washed until counts in the
wash buffer decreased to 2 x background.
We recognized that immune precipitation might still result in
non-specific co-precipitation of other material. The number of
counts precipitated and the energy level of the 3 emission from 3H
precluded using material obtained from experiments in which
[3H] phenylalanine was used to perform autoradiography. We also
found that it was not possible to incorporate sufficient counts into
immunoprecipitable protein using intravenously administered
[355] methionine. For this reason we measured incorporation of
[35S] methionine administered directly into the portal vein into
albumin and transferrin in three control SD, three HN, and four
NAR. We subjected the precipitated material to sodium ddecyl
sulfate (SDS) polyacrylamide electrophoresis PAGE followed by
autoradiography as described below.
Rats were anesthetized with pentobarbital (20 mg/100 g body
wt). The abdominal cavity was opened to expose the portal vein.
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Each rat was then given an injection of 100 jxCi [35]S-methionine
in a volume of 400 xl directly into the portal vein using a 25 gauge
needle. The needle was then removed. No significant bleeding
occurred from the portal vein following withdrawl of the needle.
After 20 minutes the animals were killed and the livers removed
and weighed. Livers were homogenized in NEP buffer (100 mM
NaC1, 1 mi EDTA, 10 m sodium phosphate, pH 7.5 and 0.1%
Triton X-100) using 2 ml per gram of tissue. The homgenate was
then centrifuged for 20 minutes at 3000 X g to remove unbroken
cells and nuclear debris. The supernatant was placed in polyal-
lomer tubes and centrifuged at 28,000 x g for one hour. Twenty
five xl of the ultracentrifugate was treated with washed Pansorbin
cells to remove non-specifically bound radioactivity. This process
was repeated until Pansorbin cells failed to bind activity greater
than 2 X background. The supernatants were immunoprecipitated
with either anti-albumin or anti-transferrin. Washed pansorbin
cells were used instead of a second antibody. After immunopre-
cipitation and washing, 75 al of Laemmle sample buffer, contain-
ing 2% SDS was added to the pansorbin cells. The samples were
then vortexed and allowed to stand either for one hour (control
and HN) or overnight (NAR), following which they were boiled
for five minutes, followed by centrifugation. Thirty d of the
supernatant was then applied onto a 4 to 15% gradient gel
(Biorad Ready Gel) and electrophoresed at 200 V for 40 minutes.
The gels were stained with Comassie Brilliant Blue R 250 and
then destained. The gels were dried and finally analyzed with a
Fujex BAS 1000 Bioimaging analyzer (Stamford, CT, USA) for a
period of 14 days in order to identify bands that had incorporated
[35S] methionine.
Protocol 2. Transferrin catabolism in the analbuminemic rat
To determine whether a reduction in transferrin catabolism
played any role in increased transferrin concentration in analbu-
minemic rats, transferrin turnover was measured in six male
Sprague-Dawley and six male Nagase analbuminemic rats. Trans-
ferrin (Organon Tecknika) was labeled with 125Jusing the Bolton
Hunter reagent [25] (New England Nuclear, Boston, MA, USA).
Approximately 30 xCi of [12511 labeled transferrin were injected in
a tail vein and blood samples of about 200 pi were obtained from
a tail vein at 5, 15, 30, 60, 120, minutes, and at 5, 10, 24, 48 and 72
hours. Three 10-xl aliquots were counted in a gamma counter
(Searle Analytics, Des Plaines, IL, USA) for 10 minutes. The
serum radioactivity disappearance curve was integrated by the
method of trapezoids using the log trapezoidal rule [26, 27]. The
dose injected (D) divided by the area under the serum radioac-
tivity curve (AUC) yields a clearance term. The product of that
clearance term (D/AUC) and serum transferrin concentration is
total transferrin turnover per unit time.
Total transferrin turnover = D/AUC X serum transferrin concentration
(Eq. 1)
At steady state, transferrin turnover is also the rate of trans-
ferrin synthesis. Since neither body weight nor serum transferrin
concentration changed during the period of measurement, trans-
ferrin turnover rate was equal to the average rate of transferrin
synthesis under the experimental conditions and is henceforth
referred to as transferrin synthesis.
Plasma volume is calculated by isotope dilution. Plasma trans-
ferrin mass (PTfM) is the product of serum transferrin concen-
tration and plasma volume. Steady state volume of transferrin
distribution (VDss) was measured by the method of Benet and
Galeazzi [26], and total transferrin mass (TTfM) is the product of
VDss and plasma transferrin concentration [28].
Transferrin and albumin were measured in plasma or serum
using an electroimmunodiffusion assay [29] as described previ-
ously [30]. Rabbit anti-rat transferrin was obtained from Organon
Teknika. Rabbit anti-rat albumin was prepared as previously
described [25].
Protocol 3. Transferrin gene expression in the rat with Heymann
nephritis; the effect of iron administration
Sprague Dawley rats (N = 15; 150 to 170 g) were rendered
nephrotic with an intraperitoneal injection of sheep antibodies
prepared against fraction FXIA to induce passive Heymann
nephritis, as described previously [31]. Seven rats were not
injected with antiserum and served as controls for the two
nephrotic groups. In our experience proteinuria reaches a plateau
on day 11 [26]. Eleven days following injection with anti-FX1A
200 xl of blood was obtained from a tail vein of each animal for
measurement of plasma Fe, transferrin and albumin and all
animals were then placed in individual metabolic cages for urine
collection. Iron was measured in initial samples using a ParamaxR
autoanalyzer (Dupont Clinical Systems Division, Wilmington,
DE, USA) [32] and the nephrotic groups were paired according to
plasma iron levels. Fifty microliters of Iron dextran, containing 50
mg of elemental Fe/ml (ImferonR, Fisons Pharmaceuticals, Roch-
ester, NY, USA) was administered subcutaneously twice a day to
seven nephrotic animals for three consecutive days. On the
morning of the fourth day all animals were anesthetized with an
intraperitoneal injection of sodium pentobarbital (20 mg/kg) and
exsanguinated by aortic puncture for measurement of plasma
proteins and Fe. The livers were rapidly removed and divided into
three portions. One portion of the liver was immediately frozen in
liquid nitrogen for subsequent analysis of steady state mRNA
levels. A second portion was used for measuring transferrin
mRNA transcription. A third piece of liver was fixed in buffered
formalin, imbedded in paraffin. Sections 3 jxm thick were stained
with Prussian blue for determination of iron stores. Iron was
measured in terminal blood. We found that the dextran interfered
with measurement of iron in some samples. For this reason we
measured total iron in these final samples using atomic absorption
spectrometry [33]. In samples in which there was no iron dextran
present the results of the two different methods used to measure
iron differed by less than 2%.
Approximately 20 xg or RNA was electrophoresed in agarose
gel and then transferred to nitrocellulose filters by capillary action
[34]. We determined whether the RNA was degraded by two
methods. Gels were permeated with ethydium bromide, visualized
with ultraviolet light and photographed. RNA samples failing to
show the characteristic bands of ribosomal RNA at 18S and at 28S
were not further evaluated.
Since mRNA might be extracted at a different efficiency than
total RNA, each RNA sample was analyzed both for transferrin
mRNA, and for the mRNA of the constitutively expressed
cytoskeletal protein, 13 actin as an internal standard. While total
hepatic protein synthesis is increased in the nephrotic syndrome
[35], synthesis of proteins retained within the liver is not increased
[30]. 13 actin is a structural protein and its mRNA is about the
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same size as that of transferrin. The expression of the /3 actin gene
should be unaffected by processes that alter expression of the
transferrin gene, and indeed, we have found that to be the case
previously [13, 16]. After transfer of RNA, each nitrocellulose
filter was analyzed using specific cDNA probes to either trans-
ferrin or to /3 actin mRNA followed by autoradiography. The
presence of degradation was detected by either the absence of the
characteristic band at 2 kilobases (kB) found with either of these
two RNA species, or the smearing of these bands. If either
situation was encountered, the RNA sample was not further
analyzed and RNA purification was repeated.
To determine the relative amount of specific mRNAs, quanti-
tative analysis was performed using dot blot analysis. Total liver
RNA was applied in duplicate to nitrocellulose filters in a
Minifold (Schliecher & Schuell) [36]. Duplicate nitrocellulose
filters were prepared so that one filter could be hybridized with a
cDNA probe prepared against transferrin mRNA (a gift from Dr.
S. McKnight [7]), and the other with a /3 actin probe and in some
cases against a cDNA probe prepared against rat albumin mRNA
(a gift from Dr. T.D. Sargent [37]). Filters were baked under UV
light for two minutes and prehybridized at low stringency. Each
was then hybridized at 42°C with the specific cDNA probes and
washed at high stringency. Air-dried filters were autoradio-
graphed overnight at —70°C. The dots containing the samples
were then cut out and counted in a scintillation counter.
Northern blot analysis revealed that all hybridization of trans-
ferrin mRNA or of /3 actin mRNA was in a single band at
approximately 2 kB. There was no evidence of hybridization with
any smaller degradation products in any group of animals. Any
changes in transferrin mRNA hybridization therefore represented
a change in full length transferrin mRNA, and not in smaller
partially degraded species. The expression of /3 actin did not vary
at all when groups of SD and NAR were compared, validating its
use as an internal standard, and increased slightly but significantly
in the HN group (32.4 cpm/jxg 0.48 vs. 28.0 cpm4tg 0.40; P
< 0.001). Increased expression of either transferrin or albumin
mRNA relative to /3 actin would then underestimate the absolute
increase in concentration of mRNA encoded by these genes by
approximately 16%.
Values for transferrin or albumin mRNA are concentrations in
relative units compared to the internal standard /3 actin and are
independent of the amount of RNA analyzed, although approxi-
mately 200 tg of tissue were used for each RNA extraction.
Synthesis of these proteins is, however, a function of total liver
mass. Since liver mass varied between the groups we also calcu-
lated total liver transferrin or albumin mRNA as a product of the
ratio of each mRNA to /3 actin mRNA and liver mass. This
product allows comparison of the relative content of each mRNA
in question in the total liver.
Nuclear run on assays
Nuclear run on assays were performed to determine whether
the increase in steady-state transferrin message resulted from an
increase in transcription. Nuclei were isolated from about 1.5 g of
liver by the method of Tata [38] for measurement of transferrin
gene transcription. Nuclei were incubated for 15 minutes at 30°C
with 166 jsCi a [32P]UTP in order to label freshly synthesized
RNA. Nuclei were treated with proteinase K (400 tg/ml) and
nuclear RNA [39] was extracted with a solution of hot phenol!
chloroform/isoamyl alcohol in a ratio of 25:24:1. Non-radioactive
0 20 40 60 80 100 120
3H incorporation into transferrin
counts incorporated /9 body weight/hr
Fig. 1. The relationship between the rate of synthesis of albumin and
transferrin in livers of normal SD rats (0) and nephrotic SD rats (S) as
measured by incorporation of [3H]phe into immunoprecipitatable albumin
and immunoprecipitatable transferrin in livers in 15 minutes. r = 0.861;P
<0.01.
cDNA's, one complementary to transferrin and another to 28S
ribosomal RNA (propagated in plasmid PBR 322, grown in E. coli
strain HB 101, obtained as a gift from Dr. Montgomery Bissel)
were incubated at 100°C in 0.66 M NaOH and fixed on a
nitrocellulose filter in a Hybri-Slot (Bethesda Research Labora-
tories, Bethesda, MD, USA). The 28S ribosomal RNA was used
as the internal control in these experiments, since only very small
amounts of /3 actin are produced during these experimental
conditions. Labeled RNA (1o cpm!ml) was hybridized to the
bound plasmid DNA. The filter was washed at high stringency,
treated with Ti RNAase, RNAase A and proteinase K, patted dry
and autoradiographed. Residual counts were a measure of [32P]
incorporated into either newly synthesized 28S ribosomal RNA or
into newly synthesized transferrin mRNA, Each dot was quanti-
tated by densitometry. The rate of incorporation of [32P] into
transferrin mRNA was determined relative to the rate of incor-
poration of [32P] into 28S ribosomal RNA by calculating the ratio
of densities of the dots.
Protocol 4. Transferrin gene expression in the analbuminemic rat
Six male analbuminemic rats and six normal Sprague-Dawley
rats were anesthetized with sodium pentobarbital (20 mg/kg i.p.
and exsanguinated as described above. The livers were removed,
blotted dry and weighed. Approximately 500 mg of liver was then
homogenized in 4 M guanidinium thiocyanate, followed by cen-
trifugation through 5.7 M CsCl [40]. Transferrin mRNA content
was then determined by quantitative dot blot hybridization as
above. The relative rate of transferrin gene transcription was
measured relative to 28S ribosomal RNA in liver nuclei as
described above.
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Fig. 2. Autoradiogram of SDS polyac,ylamide gel
analyzing [35]S methionine incoiporated into
transferrin (upper panels) or albumin (lower
panels) in livers of control SD rats (left 3 lanes),
rats with passive Heymann nephritis (HN)
(middle 3 lanes) or Nagase analbuminemic rats
(NAR) (right 4 lanes).
Table 2. Transferrin catabolism and distribution in Nagase analbuminemic rats
Group
Weight
g
Plasma
transferrin
mg/mi
Plasma
volume
% body wt
Plasma Total
transferrin transferrin
mass mass
Transferrin
synthesis
mg/i 00 g/hr
Transferrin
catabolism
% plasma
pool/hr
Plasma
iron
1ug/dlmg/IOU g body wt
SDN=6 271±11 6.8±0.3 4.8±0.05 31.6±2.3 47.6±3.8 1.67±0.09 5.34±0.21 158±9.0
NARN=6 263± 10 9.0±0.2a 4.73±0.10 42.6±2.Oa 61.4±2.0a 2.28±0.la 5.36±0.20 210±30
Transferrin distribution and metabolism in normal male rats with hereditary analbuminemia (NAR) were compared to normal Sprague-Dawley (SD)
rats. Transferrin synthesis is in mg/100 g body wt/hr, and tansferrin catabolism is a fractional catabolic rate; % of plasma pool catabolized/hour. Data
are means SEM.
P < 0.01 vs. SD
Measurement of transferrin mRNA in testis
The testes were removed from NAR and SD rats in protocol 4
as well as from four nephrotic rats and immediately frozen in
liquid nitrogen. RNA was subsequently extracted as described
above and analyzed for transferrin mRNA relative to /3 actin
mRNA using quantitative dot blot hybridization. Each measure-
ment was performed in duplicate. The mean value of each
measurement was used in the final calculations of the ratios of
transferrin mRNA to /3 actin mRNA.
Statistics
Statistical analysis was performed using a one way analysis of
variance [41] with post hoc Student Newman Keuls comparison. A
P value of <0.05 was considered to be statistically significant.
Results
Hepatic transferrin synthesis, measured directly as [3H] phenyl-
alanine incorporation into hepatic protein, was increased both in
livers of NAR and in HN rats (Table 1). Transferrin concentration
was increased significantly in the plasma of NAR and reduced in
the plasma of HN (Table 1). Transferrin synthesis in HN and
normal SD correlated with albumin synthesis (r = 0.86, P < 0.001)
in livers of HN and SD rats in which the synthesis of both proteins
was measured (Fig. 1). Albumin synthesis was nearly absent in the
livers of NA rats.
Analysis of incorporation of [35S] methionine into specific
proteins by autoradiography revealed a single band of radioactive
material running at the molecular weight of transferrin following
SDS polyacrylamide gel electrophoresis when antibody against
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Table 3. Hepatic transferrin gene expression in analbuminemic rats
Group
Weight Liver weight Plasma
transferrin
mg/mi
Transferrin mRNA/
/3 actin mRNA
Transferrin mRNA
transcription/ 28S
RNAg
SD N = 6 195 2.2 8.34 0.31 5.25 0.09 0.817 0.095 1.02 0.04
NAR N = 6 188 5.7 12.32 Q,55a 7..31 O.1P 1.265 0.156 1.53 o.loa
Plasma transferrin was measured in a group of normal male SD and NAR. The relative concentration of transferrin mRNA to /3 aetin mRNA was
measured in liver by dot blot hybridization and the rate of transcription of transferrin mRNA was measured relative to that of 28S ribosomal RNA as
the incorporation of [32]P into RNA in nuclei isolated from liver. Data are means suM.
aP C 0.05 vs. SD
Table 4. Effect of iron on hepatic transferrin gene expression in the rat with Heymann nephritis
Group
Plasma Plasma Urinary Urinary
Weight Liver weight . transferrin albumin transferrin albuminLiver
g weight% mg/mi mg/day
SD N = 7 246 7.2 9.85 1.11 4.18 0.21 7.65 0.19 28.3 2.1 NM NM
HN N = 8 209 8.8k' 13.12 o.8P 6.24 0.20a 2.77 0.1T 7.77 0.61a 79.9 4.5 531 28
NH + Fe N = 7 225 8.3' 13.61 1,04 6.03 Ø37a 3.19 0.1& 10.25 0.ola 79.8 10.6 530 65
Table 4. Continued
Group
Plasma iron
pg/di
Total Transferrin
Transferrin mRNA/ transferrin transcription Albumin mRNAJ Total albumin
/3 aetin mRNA mRNA /28S /3 actin mRNA mRNA
SD N = 7 234.1 17.1 6.52 0.58 65.3 9.6 1.09 0.19 1.21 0.08 14.6 1.04
HN N = 8 224.8 17.3 8.60 Q•59 115.1 11.& 1.81 0.20a 2.45 0.14 33.3 3.8a
NH + Fe N = 7 6028 iiso" 9.44 1.la 113.4 13.2a 1.96 o.22a 2.01 0.22 29.1 3.8a
Rats were rendered oephrotic by administration of antibodies to FXIA. Iron dextran was administered to one chohort of nephrotic rats to determine
whether iron supplementation would modulate the effect of proteinuria on transferrin gene expression. Transferrin and albumin mRNA levels were
determined relative to /3 actin mRNA and transcription of transferrin mRNA was determined relative to 28 5 ribosomal RNA. Concentrations of
albumin and transferrio mRNA are in counts hybridized to each specific mRNA relative to /3 actin as an internal standard, are without units and depend
on the specific activity of the eDNA probes used for hybridization as well as on the amount of RNA extracted. Total mRNA of either albumin or
transferrin is also unitless and is the product of the ratio obtained and liver weight. This value provides a comparison of the relative amounts of total
liver albumin and transferrin mRNAs in the three groups. Data are means 5EM.
aP C 0.01 vs. SD
transfcrrin was used and that over 90% of radioactivity was in a
single band running at the molecular weight of albumin (Fig. 2).
Serum iron was decreased in the nephrotic animals compared
to control SD (P < 0.02; Table 1) possibly providing a mechanism
for stimulation of transferrin synthesis. However, serum iron was
normal in NAR. Prussian blue staining revealed increased staining
in animals treated with iron dextran.
Plasma volume was the same in NAR and SD (4.7% body wt
0.1 vs. 4.8% body wt 0.05; Table 2). Serum transferrin concen-
tration, plasma transferrin mass and total transferrin mass were all
significantly increased in NA rats. Total body transferrin synthesis
(turnover) was increased in NA rats although plasma iron was no
different from that in normal SD rats (Table 2). The fractional
rate of transferrin catabolism was unchanged. The increase in
plasma transferrin mass thus resulted from an increase in its rate
of synthesis alone, and not from an alteration in its rate of
catabolism.
Steady state transferrin mRNA concentration was increased by
30% in livers of NAR versus SD (P < 0.05) by cDNA dot blot
hybridization (Table 3). As in the case of nephrotic rats (Table 4),
the increase in steady state transferrin mRNA concentration in
the livers of analbuminemic rats was accompanied, and most likely
caused by an increase in the rate of transcription of this gene.
Transferrin synthesis was thus increased in NAR rats in the
absence of reduced plasma Fe, increasing plasma and total body
transferrin mass, suggesting non-iron dependent regulation of
hepatic transferrin synthesis in the NAR at the level of transferrin
gene expression.
Steady-state transferrin mRNA levels was increased approxi-
mately twofold in the livers of nephrotic rats (Table 4). The
increase in transferrin mRNA in the liver was accompanied by an
increase in the rate of its transcription (Table 3). Neither the
augmentation in transcription of this gene nor the increase in its
mRNA level in the liver of nephrotic rats were suppressed by
administration of iron in sufficient amounts to greatly increase
liver iron stores (Fig. 3C) and plasma iron concentration (Table
4).
While transferrin mRNA concentration in liver was increased
(relative to /3 actin mRNA) total transferrin mRNA mass was also
increased as a consequence of increased liver mass in both HN
and NAR. The combination of these two processes led to
approximately a doubling of total liver transferrin mRNA content
in HN (Table 4). We previously established that increased liver
mass was not a consequence of edema, but instead resulted from
hypertrophy in HN and hyperplasia in NAR [42]. In both cases
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Fig. 3. Photomicrographs of livers from normal
SD rats (A), nephrotic SD rats (B) and nephrotic
SD rats treated with iron (C). Sections were
stained with Prussian blue in order to detect
iron. Final magnification is X180.
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Fig. 4. The relationship between the concentrations of albumin mRNA
(relative to 13 actin mRNA) and transferrin mRNA (relative to (3 actin
mRNA) in the livers of nonnal SD rats (0), nephrotic SD rats (0) and
nephrotic SD rats treated with iron (A).
total liver RNA was increased. In RN, liver RNA was also
increased per gram of liver.
Albumin mRNA was measured in the livers of several rats in
each group as a positive control and was found to be increased as
previously reported [311. The increase in hepatic transferrin
mRNA content was not altered by iron administration (Table 4)
and correlated positively with albumin mRNA in livers in which
both mRNAs were measured (Fig. 4). In contrast to liver,
transferrin mRNA was reduced slightly but not significantly in the
testis of NAR and, surprisingly, was reduced significantly in the
testis of RN (Table 5).
Discussion
Transferrin synthesis is increased both in patients [1] and in rats
with the nephrotic syndrome. We have shown here that, like
albumin and several other proteins [13, 15, 16, 19, 20], increased
hepatic transferrin synthesis is regulated, at least in part, at the
level of gene transcription. While transferrin synthesis may be
increased under some circumstances as a component of the acute
phase cascade [43] or as a consequence of iron deficiency [7,17],
neither stimulus appears to be responsible for increased trans-
ferrin synthesis in the rat with RN. Although iron levels are
reduced in nephrotic rats, supplementation with sufficient iron
even to the point of causing clearly increased hepatic iron stores
(Fig. 2C) does not reduce transcription of the transferrin gene in
RN at all, nor does it alter plasma transferrin levels in these
animals. It is unlikely that transferrin synthesis is increased as a
component of the acute phase cascade since synthesis of albumin,
a negative acute phase reactant protein [44], is augmented.
In the NAR, plasma protein levels are essentially the same as in
normal Sprague-Dawley rats [45] because of an increased concen-
tration of a number of other proteins [10] including transferrin.
The absence of albumin from the plasma of these animals has no
effect on transferrin catabolism. The increase in transferrin con-
centration is entirely a consequence of increased transferrin
synthesis unaccompanied by a change in its fractional catabolic
rate. As in the nephrotic syndrome, increased transferrin synthesis
in the NAR is a consequence of increased transferrin gene
transcription in the liver. Augmentation of hepatic gene transcrip-
Testicular
Group
Weight weight .Transferrin mRNA
/3 actin mRNAg
SD N = 4 195 2,2 2.08 0.10 2.39 0.27
NAR N = 4 188 5.5 1.51 0.04 1.99 0.20
RN N = 4 214 10.6 2.35 0.06 1.44 o.13
tion takes place in the NAR in the absence of proteinuria, in the
absence of any evidence of extracorporeal iron loss and in the
presence of an increased, rather than a decreased plasma trans-
ferrin concentration.
Although albumin and fibrinogen, two proteins whose rate of
synthesis is increased at the level of gene transcription [13, 31, 37]
in the nephrotic syndrome, are synthesized exclusively in the liver,
several of the proteins whose rate of synthesis is increased in the
nephrotic syndrome are also synthesized in extrahepatic tissue.
Apo A-I is synthesized in both liver and intestine, but increased
transcription occurs in only the liver [15, 16] in the nephrotic
syndrome and not in the gut [15]. While transferrin gene tran-
scription is increased in the liver, as shown here, expression of this
gene is suppressed in the testis in the nephrotic syndrome.
The liver becomes hypertrophic shortly after the onset of
proteinuria [13] as a consequence of increased hepatic protein
synthesis [46]. Thus the liver appears to be the principal organ
whose function is affected in these two conditions characterized by
decreased plasma albumin concentration and decreased ir, in this
case recruiting transcription of the transferrin gene by a non-iron
dependent mechanism. These observations are consistent with a
hypothesis that synthesis of both proteins is increased at the
transcriptional level, specifically in the liver, during conditions
when either plasma albumin concentration or r is reduced.
Tissue specific expression of genes encoding proteins secreted
by the liver is orchestrated by a group of transcription factors
expressed primarily in the liver [47, 48] that bind to consensus
sequences found in the untranslated regions flanking these genes,
usually binding to the 5' flanking regions [49], or less frequently to
introns or elsewhere in proximity to the structural elements of the
gene [50]. Expression of a group of genes therefore can be
modulated together by changing the levels or activity of a specific
DNA binding protein [51]. One such group of proteins is the acute
phase reactive proteins [52]. Although these genes may be ex-
pressed in several tissues, they respond as part of the acute phase
cascade only in the liver [53]. We recently found that plasma from
both NAR and RN stimulated synthesis of both albumin and
transferrin in isolated hepatocytes (H4 cells) in culture [42]. This
observation suggests that alterations in hepatic expression of both
albumin and transferrin might also be modulated by a factor or
group of factors in plasma.
It is unlikely that expression of all genes encoding proteins
secreted by liver are regulated in a similar manner in the
nephrotic syndrome or in the condition of hereditary analbumin-
emia, Among the apolipoproteins, hepatic synthesis of apo E, B
and A-I are all increased [12], while synthesis of the apo C
C
I
25
20
15
10
5
0-
20
a.
S
Table 5. Testicular transferrin mRNA levels in analbuminemic (NAR)
and nephrotic (RN) rats
ocP A0
30 4 50 60
The concentration of transferrin mRNA relative to that of (3 actin was
measured in testis of SD, NAR and rats with Reymann nephritis (RN).
Data are means 5EM.
ap < 0.01 vs. SD
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apolipoproteins is not increased at all. Among these, synthesis of
only apo A-I is mediated at the level of gene transcription [15, 16].
We recently reported [13] that, while hepatic synthesis of both the
positive acute phase reactive protein, fibrinogen, and the negative
acute phase reactive protein, albumin, were positively correlated
and both increased at the level of transcription, there was no
relationship between the rate of synthesis of the positive acute
phase reactive protein, a acid glycoprotein (a1 AG), and that of
either albumin or fibrinogen, and no change in the rate of
transcription of the a1 AG gene. Thus it is possible that synthesis
of both albumin and transferrin is stimulated in the nephrotic
syndrome and in the condition of hereditary analbuminemia as
part of an array of proteins responding in some ways in a manner
analogous to the acute phase cascade.
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